Tracking defects caused by brain tumor mutation yields insight to advance targeted therapy
St. Jude Children's Research Hospital scientists have gained ground toward developing more targeted therapies for the most common childhood brain tumor. The findings appear today in the Journal of Molecular Biology.
May 8, 2015
0
14